Back to results
US 2023/0338516 A1Published application
Recombinant poxviridae vector expressing co-stimulatory molecules
AssigneePrime Vector Technologies GmbH
InventorsMelanie MUELLER, Ralf AMANN
Life of this patent
Estimating the term…
Abstract
The present invention relates to a recombinant Poxviridae vector expressing a co-stimulatory molecule, a cell containing the recombinant Poxviridae vector, a pharmaceutical composition containing the recombinant Poxviridae vector according to the invention and/or the cell according to the invention, and a method for the treatment of a living being in need of a vaccination with an antigen.
Claims15
A recombinant Poxviridae vector, which comprises the following:
- at least one first nucleotide sequence encoding and expressing a co-stimulatory molecule, and
- at least one promoter controlling the expression of the first nucleotide sequence.
Dependencies are inferred from the claim text.